ELAVL1 and rheumatoid arthritis: Taken together, our findings imply that Alu RNA editing may be a global primate-specific mechanism controlling Alu-enriched inflammatory mediators at post-transcriptional level through HuR-mediated RNA processing/stability in patients with RA.